Concord Biotech Announcements
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 scheduled to be held on March...
26 Feb, 2026 | 02:33pm • Source: BSE
Concord Biotech Limited has informed the Exchange about Schedule of meet
20 Feb, 2026 | 11:05am • Source: NSE
Concord Biotech Limited has informed the Exchange about Schedule of meet
20 Feb, 2026 | 11:04am • Source: NSE
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 scheduled to be held on 26th...
20 Feb, 2026 | 10:17am • Source: BSE
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 scheduled to be held on 25th...
20 Feb, 2026 | 10:10am • Source: BSE
Q3FY26 Earnings Call Audio
12 Feb, 2026 | 06:28pm • Source: BSE
Newspaper Publication cutouts Q3 - FY 2025-26
12 Feb, 2026 | 06:18pm • Source: BSE
With reference to the BSE''s email L/SURV/ONL/PV/APJ/2025-26/908 dated February 09, 2026, The Company hereby clarifies that the Company is in Compliance with Regulation 30 of...
09 Feb, 2026 | 12:44pm • Source: BSE
The Exchange has sought clarification from Concord Biotech Ltd on February 9, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
09 Feb, 2026 | 12:27pm • Source: BSE
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, read with Para A of...
06 Feb, 2026 | 11:48am • Source: BSE
Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and...
06 Feb, 2026 | 10:20am • Source: BSE
Concord Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
06 Jan, 2026 | 10:54am • Source: NSE
Enclosed herewith the certificate under Regulation 74(5) of the SEBI (DP) Regulations,2018 for the quarter ended 31.12.2025
06 Jan, 2026 | 10:39am • Source: BSE
Intimation of Trading window closure from 1st January,2026
26 Dec, 2025 | 09:42am • Source: BSE
Ms. Hina Patel, has tendered her resignation from the post of Company Secretary and Compliance Officer w.e.f 21/01/2026 after close of working hours.
24 Dec, 2025 | 05:28pm • Source: BSE
Change in KMPs Authorization for determining materiality of Event and Information to the Stock Exchanges
18 Dec, 2025 | 01:50pm • Source: BSE
Appointment of Mr. Raviraj Karia as CFO and KMP of the company w.e.f. 18/12/2025
18 Dec, 2025 | 12:58pm • Source: BSE
Appointment of Mr. Raviraj Karia as Chief Financial Officer and KMP
18 Dec, 2025 | 12:54pm • Source: BSE
Concord Biotech Limited has informed the Exchange regarding Resignation of Mr Lalit Sethi as Chief Financial Officer of the company w.e.f. January 05, 2026
08 Dec, 2025 | 02:24pm • Source: NSE
Early Retirement of Chief Financial officer (KMP) w.e.f. closing of working business hours on January 05,2026
08 Dec, 2025 | 01:53pm • Source: BSE